Investor Presentaiton

rebates, payments, and fees collected from drug manufacturers and pharmacies. Prior to 2023, PBM reporting requirements have been established in 16 other states. 25 Figure 18: Before 2023, other states have passed laws requiring greater reporting for PBMs AK HI WA MT ND MN WI OR NV WY IA NE MO ME VT NH NY MA RI IN OH PA NJ WV VA MD DE UT NM KS AR TN NC SC DC AZ OK LA MS AL GA TX FL PBM reporting requirements Source: National Council of State Legislatures To better understand this complex and often opaque system, policymakers should have information available to them to make informed decisions and help determine whether PBMs and other key players are providing benefits and delivering good value to Oregonians. Figure 19 compares Oregon to other states that require PBMs to report certain financial information. Oregon's initiatives were only recently adopted in the 2023 session, but the Legislature should require PBMs to report admin fees and spread pricing retained, as well as collecting de-identified data. Figure 19: Oregon lacks some of the aggregated PBM transparency initiatives adopted in other states OR CT GA IN ΙΑ LA MI MN MT NV NH NY TX UT VT Drug rebates from drug manufacturers or other sources Drug rebates passed though and/or retained Admin fees from health plans Admin fees from pharmacies Admin fees from drug manufacturers All admin fees retained Spread pricing retained Data collection Public reporting 25 In the 2023 session, the Oregon Legislature passed Senate Bill 192, which requires PBMS to submit some information annually to DCBS. Oregon Secretary of State | Report 2023-25 | August 2023 | page 24 VA WI

View entire presentation